Jon Rodney Resar MD
Interventional Cardiology
Professor of Medicine/Cardiology Johns Hopkins University School of Medicine
Join to view full profile
601 North Caroline StreetSuite 7200Baltimore, MD 21287
Phone+1 443-997-0270
Fax+1 410-614-1168
Dr. Resar is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Jon Resar is a cardiologist specializing in interventional cardiology, based in Baltimore, MD. He completed his medical education at the Medical College of Wisconsin and his residency and fellowship at Johns Hopkins University, where he is currently a professor. His expertise includes general cardiology, myocardial infarction, valvular heart disease, interventional cardiology, and cardiac catheterization. He has authored several publications in prominent medical journals and contributed to clinical trials focused on aortic stenosis. Dr. Resar has been recognized as one of America's Top Doctors and has received multiple awards from Castle Connolly.
Education & Training
Johns Hopkins UniversityFellowship, Cardiovascular Disease, 1988 - 1992- Johns Hopkins UniversityResidency, Internal Medicine, 1985 - 1988
Medical College of WisconsinClass of 1985
Certifications & Licensure
MD State Medical License 1989 - 2027
FL State Medical License 2013 - 2022
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Cardiovascular Disease
- American Board of Internal Medicine Interventional Cardiology
Awards, Honors, & Recognition
- Fellow, Society Cardiovascular Angiography and Interventions
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification Beacon Oncology 2014 Certified Module, Epic Systems Corporation, 2014, 2016-2017
Clinical Trials
- Safety and Efficacy Study of the Medtronic CoreValve® System in the Treatment of Symptomatic Severe Aortic Stenosis in High Risk and Very High Risk Subjects Who Need Aortic Valve Replacement Start of enrollment: 2010 Dec 10
- Safety and Efficacy Study of the Medtronic CoreValve® System in the Treatment of Severe, Symptomatic Aortic Stenosis in Intermediate Risk Subjects Who Need Aortic Valve Replacement (SURTAVI).
- Safety & Efficacy Study of the Medtronic CoreValve® System-Treatment of Symptomatic Severe Aortic Stenosis With Significant Comorbidities in Extreme Risk Subjects Who Need Aortic Valve Replacement
Publications & Presentations
PubMed
- Transcatheter Aortic Valve Replacement in Low-Risk Patients at Four or More Years.John E Connolly, Seyed Hossein Aalaei Andabili, Emily Joseph, Jon Resar, Faisal Rahman
The American Journal of Medicine. 2024-10-01 - 7 citationsTranscatheter Closure of Postinfarct VSD With the Amplatzer PIVSD Occluder: Results of a US Study.Vijay Iyer, Courtney Weiler, William Merhi, Biswajit Kar, J Curtis Fudge
Journal of the Society for Cardiovascular Angiography & Interventions. 2024-06-01 - 7 citationsImpact of the COVID-19 Pandemic on Global TAVR Activity: The COVID-TAVI Study.Xavier Armario, Jennifer Carron, Andrew J Simpkin, Mohamed Elhadi, Ciara Kennedy
JACC. Cardiovascular Interventions. 2024-02-12
Journal Articles
- Original Research Self-Expanding Transcatheter Aortic Valve Replacement in Patients with Low-Gradient Aortic StenosisHarold L Dauerman, Jon R Resar, Steven J Yakubov, P Michael Grossman, Stanley J Chetcuti, G Michael Deeb, Jeffrey J Popma, Jae K Oh, ScienceDirect
- Fentanyl Delays the Platelet Inhibition Effects of Oral Ticagrelor: Full Report of the PACIFY Randomized Clinical TrialDavid R Thiemann, Khalil Ibrahim, Thomas S Kickler, Rohan Shah, Roger S Blumenthal, Rani K Hasan, Steven P Schulman, Rakesh R Goli, John W McEvoy, Jon R Resar, Thrombosis and Haemostasis
Press Mentions
As Cardiology Fellowship Programs Mushroom, Who’s Keeping Tabs on Quality and Numbers?August 2nd, 2019
Should There Be a Hybrid Training Model for SHD?February 12th, 2018
Device Registry Tool Allows Early Safety AlertingJanuary 25th, 2017
Grant Support
- Effects Of Ischemia On Coronary Artery Flow In The DogNational Heart, Lung, And Blood Institute1990
Professional Memberships
- Member
External Links
- Johns Hopkins Physicianshttp://www.hopkinsmedicine.org/jon-resar
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
